New 'Off-the-Shelf' cell therapy takes on Hard-to-Treat cancers
NCT ID NCT06241456
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This early-stage study tests a new cancer treatment called FT825, a type of CAR T-cell therapy that is made from donor cells and does not need to be personalized. It is given with or without additional antibody drugs to people with advanced solid tumors that have HER2 or other markers. The main goals are to check safety and find the right dose, while also seeing if the treatment can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Banner MD Anderson Cancer Center
RECRUITINGGilbert, Arizona, 85234, United States
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
OU Health Stephenson Cancer Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
-
Ohio State University - Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
-
Oncology Hematology Care Clinial Trials
RECRUITINGCincinnati, Ohio, 45242, United States
-
Sarah Cannon Research Institute (SCRI) - Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Thomas Jefferson University, Sidney Kimmel Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
University of California San Diego Moores Cancer Center
RECRUITINGLa Jolla, California, 92037, United States
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
-
University of Minnesota Medical School
RECRUITINGMinneapolis, Minnesota, 55455, United States
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
-
Yale New Haven Hospital - Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.